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Abstract
Background: Micronutrients are necessary for fetal growth. However increasingly pregnant women are nutritionally
replete and little is known about the effect of maternal micronutrient intakes on fetal adiposity in mothers with
increased BMI. The aim of this study was to examine the association of maternal dietary micronutrient intake with
neonatal size and adiposity in a cohort at risk of macrosomia.
Methods: This was a cohort analysis of 554 infants from the ROLO study. Three day food diaries from each trimester
were collected. Neonatal weight, length, circumferences and skinfold thicknesses were measured at birth. Multiple
linear regression was used to identify associations between micronutrient intakes and neonatal anthropometry.
Results: Birthweight was negatively associated with maternal trimester 3 vitamin D intake and positively associated
with trimester 3 vitamin B12 intake R2adj 19.8 % (F = 13.19, p <0.001). Birth length was positively associated with
trimester 3 magnesium intake R2adj 12.9 % (F = 8.06, p <0.001). In terms of neonatal central adiposity; abdominal
circumference was positively associated with maternal trimester 3 retinol intake and negatively associated with
trimester 3 vitamin E and selenium intake R2adj 11.9 % (F = 2.93, p = 0.002), waist:length ratio was negatively
associated with trimester 3 magnesium intake R2adj 20.1 % (F = 3.92, p <0.001) and subscapular:triceps
skinfold ratio was negatively associated with trimester 1 selenium intake R2adj7.2 % (F = 2.00, p = 0.047).
Conclusions: Maternal micronutrient intake was associated with neonatal anthropometry even in women not
at risk of malnutrition. Further research is necessary to determine optimal micronutrient intake in overweight
and obese pregnant women.
Trial registration: Current Controlled Trials ISRCTN54392969.
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Introduction
Micronutrients are necessary for normal growth and
development of the fetus and deficiencies have been
found to be associated with intrauterine growth retard-
ation and small for gestational age (SGA) infants [1, 2].
In developing countries, supplementation with single [3]
or multiple [4] micronutrients has been found to in-
crease birthweight and reduce risk of SGA. However in
the developed world, where pregnant women are nutri-
tionally replete and increasingly over-nourished with the
risk of macrosomia (birthweight >4 kg or >95th centile)
increasing, little is known about micronutrient intakes in
pregnant women in relation to fetal size and adiposity.
The prevalence of overweight and obesity has increased
in women of childbearing age and is associated with in-
creased levels of offspring macrosomia, childhood and
later-life overweight and obesity which is thought to
occur through metabolic programming [5]. In addition,
levels of inflammation naturally increase during preg-
nancy, mediated by the placenta. The combination of
pregnancy and maternal overweight or obesity leads to a
chronic inflammatory environment which is thought to
affect the fetus indirectly (as cytokines are negligibly
directly transferred across the placenta) by increasing
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glucose and lipid availability [5, 6]. The increased avail-
ability of glucose and lipids results in increased fetal
growth and fat deposition [6]. Micronutrients have many
functions, for example some may be involved in drug-
nutrient interactions, antioxidant processes, interactions
with intercellular signalling proteins, transcriptional
regulation, cell proliferation, platelet aggregation and
monocyte adhesion as well as other as yet unknown
functions [7, 8]. In addition, there appears to be a syner-
gistic action of micronutrients in food both with each
other and with other food components [9]. Finally,
micronutrients may also act simply as markers of
healthy overall diet and lifestyle confounding the rela-
tionship between their mechanisms of action and health
outcomes [10]. Due to the multiple possible mechanisms
of action, some of which have not fully been uncovered,
and to the fact that micronutrients alone may not be
resulting in certain health benefits with which they are
associated, but rather the health behaviours their con-
sumers undertake, the effect of dietary consumption of
micronutrients is not yet fully understood and supple-
mentation with these micronutrients does not always
give the expected result [10].
Animal models have shown that micronutrient defi-
ciency may increase offspring adiposity at birth. Antioxi-
dant supplementation has been found by one study to
reduce the effect of maternal obesity on neonatal adipos-
ity in rats [11]. Another study found that maternal anti-
oxidant supplementation also reduced the inflammatory
destruction of murine fetal pancreatic β-cells reducing
development of type II diabetes [12]. Vitamin D deficiency
has similarly been found to be associated with increased
risk of gestational diabetes in human studies [13] however
human clinical trials are ongoing to determine causality.
There remains a paucity of data on the effect of micronu-
trient intakes on human offspring adiposity, except in the
prevention of low birthweight [14]. Therefore, the aim of
this study was to examine the influence of maternal diet-
ary micronutrient intake in pregnancy on neonatal weight,
length and adiposity using a cohort at risk of macrosomia
from the ROLO (Randomised cOntrol trial of LOw gly-
caemic index diet versus no dietary intervention to pre-
vent recurrence of fetal macrosomia) study [15].
Methods
Five hundred forty-two mother and infant pairs from the
ROLO study were included in this analysis. The ROLO
study was a randomised control trial of 800 secundigra-
vid women with a previous macrosomic baby (>4 kg)
randomised to receive low glycaemic index (GI) dietary
advice versus usual care (no dietary advice) to reduce
recurrence of macrosomia [16]. The ROLO study was
carried out at the National Maternity Hospital, Ireland
between January 2007 and January 2011 and detailed
methodology and results have previously been published
[15]. In brief; the primary outcome, a reduction in birth-
weight was not achieved and the secondary outcomes, a
reduction in gestational weight gain and glucose intoler-
ance, were achieved. Low GI dietary advice was given at
week 14 of pregnancy while demographic, well-being
and lifestyle questionnaires were returned by 28 weeks
gestation. Three-day food diaries were completed at each
trimester of pregnancy and used to determine the gly-
caemic index and glycaemic load of the mothers’ diets.
The control group received routine antenatal care which
did not involve dietary advice. This study was conducted
according to the guidelines laid down in the Declaration
of Helsinki and all procedures involving patients were
approved by the National Maternity Hospital, Ireland
ethics committee. Written informed maternal consent
was obtained from all participants. The work presented
here will use the dietary and anthropometric data from
the ROLO study in order to carry out a secondary ana-
lysis examining the association of maternal micronu-
trient intake and neonatal size and adiposity.
Inclusion and exclusion criteria
Participants were secundigravid women who had previ-
ously given birth to a macrosomic baby (>4 kg). They were
required to have sufficient literacy and fluency in the Eng-
lish language to understand the intervention and be cap-
able of completing questionnaires. Women were included
if they were over 18 years old and free from underlying
health conditions and if they had healthy, singleton preg-
nancies without any intrauterine growth abnormalities.
Maternal demographics and lifestyle
Of the 800 participants of the ROLO study, 759
completed the original trial and had their infants’ an-
thropometry measured at birth. Of these, 542 completed
and returned all questionnaires and food diaries.
Questionnaires completed in the first half of pregnancy
explored various background socioeconomic and socio-
demographic, and lifestyle variables. Questions from
SLAN (Survey of Lifestyle, Attitudes and Nutrition in
Ireland) [17] relating to lifestyle habits were completed
at this time, including questions on number of 20 min
intervals of mild, moderate and strenuous physical activ-
ity per week and on number of days per week walking
for over 30 min, on smoking and alcohol consumption,
on educational attainment and on supplement use.
Maternal and neonatal anthropometry
Maternal weight (kg), height (cm) and mid-upper arm
circumference (cm) were measured at the first antenatal
consultation and BMI was calculated. Maternal weight
was also measured at each subsequent consultation and
gestational weight gain was calculated.
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Neonatal weight (kg), length (cm), mid-upper arm, ab-
dominal, hip and thigh circumference (cm), and biceps,
triceps, subscapular and thigh skinfold (mm) measure-
ments were taken at birth. Weight and length were
measured for all 542 neonates while other anthropo-
metric measurements were available for 266 neonates
as these measurements began to be taken later in the
study. Waist:hip, waist:length and subscapular skin-
fold:triceps skinfold ratios were calculated as were
sum of triceps and subscapular skinfold thicknesses
and sum of all skinfold thicknesses were in order to
measure neonatal adiposity. The most commonly
reported anthropometric parameters, “weight” and
“length”, are very limited measures of adiposity which
give no information on body fat distribution. There-
fore, the more in-depth measurements above were
used. Circumferences and skinfolds describe body
weight distribution with skinfolds giving a measure of
subcutaneous fat. Multiple-site skinfolds have been
found to be more accurate than single site skinfolds
and subscapular-to-triceps skinfold ratio measurement
has been found to be reflective of central adiposity in
children and correlates well with BMI and waist
circumference [18, 19]. Waist:height ratio has been
found to be a good measure of central adiposity in
adults and children with a ratio of ≥0.5 indicating ex-
cess central adiposity [20]. A study by Brambilla et al.
found it to be a better measure of adiposity than
waist circumference or BMI in children and adoles-
cents [21]. Waist circumference to height ratio has
also been found to be capable of identifying children
with increased cardiometabolic risk factors with some
studies [22, 23] finding it a better identifier of cardio-
vascular disease risk than BMI.
Maternal dietary intake
Three-day food diaries were completed at each trimester
of pregnancy and used to determine maternal energy
and micronutrient intake. Micronutrient intake during
each trimester of pregnancy was examined separately
and adjusted for maternal energy intake.
All food diaries and food frequency questionnaires
were entered by a trained dietitian with the use of the
household measures and UK Food Standards Agency
average portion sizes [24]. Food Diaries were analysed
using Tinuviel WISP software, version 3.0, in which the
food composition tables used are derived from the 6th
edition of McCance and Widdowson’s Food Compos-
ition Tables. Underreporting was examined using Gold-
berg ratios i.e. the ratio of energy intake to estimated
basal metabolic rate. Basal metabolic rate was calculated
using Schofield equations and a Goldberg ratio of ≤0.9
was used to identify definite underreporters [25, 26].
Vitamin and mineral supplement use was reported as a
binary yes/no answer in questionnaires.
Statistical analysis
Statistical analysis was completed using SPSS (Statistical
Package for the Social Sciences) software version 20.0.
Statistical analyses involved correlations, independent
sample t-tests and ANOVA and simple and multiple lin-
ear regression modelling. The intervention and control
groups were analysed both separately and together to
ensure all results were representative of both groups.
Since there was no difference in neonatal anthropom-
etry except for thigh circumference [27] and waist:
length ratio between the control and intervention
groups, groups were analysed together for final ana-
lysis but group was controlled for in all final models.
Micronutrients were examined per 10 MJ energy. As-
sociations between macro- and micro-nutrients and
neonatal anthropometry were first examined using
correlations. Variables that were found to be signifi-
cantly associated with neonatal anthropometry were
further analysed using simple linear regression, then
input into the final multiple regression model for
well-being using a forced enter and backwards step-
wise approach. While the focus of this analysis was to
examine the associations between maternal micronu-
trient intakes and neonatal adiposity, macronutrients
were also examined in order to determine whether
micronutrients were independently associated with
offspring adiposity or were simply acting as markers
of macronutrient intakes. Both macronutrients and
micronutrients that were statistically significantly as-
sociated with neonatal anthropometry using simple
linear regression were included in a backwards step-
wise multiple regression block resulting in any non-
significant variables being discarded from the model
in a stepwise manner. Variables known to affect neo-
natal size (maternal education level as a marker of
socioeconomic status, pre-pregnancy BMI, length of
gestation and neonate gender), were controlled for
using a forced enter multiple regression block in all
models. As mentioned, membership of the control or
intervention group was also included in these models.
Underreporting of dietary intake was addressed by re-
moving definite underreporters (Goldberg ratio ≤0.9)
from the multiple linear regression analysis. Supple-
ment use was also controlled for in the final multiple
linear regression models. Multiple linear regression
resulted in a best and final model and models that
were statistically significant overall (p <0.05) were
chosen as those which best predicted neonatal adipos-
ity. Compliance with Irish recommended dietary al-
lowances [28] was also examined using the population
compliance method [29].
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Sample size for maternal micronutrient effect on neonatal
skinfolds
We used information from a previous publication [30] to
obtain a standard deviation for a sum of skinfolds (SS+TR)
measure, and to obtain regression analysis effect sizes for a
generic standardised predictor variable (SD = 1). The sam-
ple sizes to detect an effect in linear regression of SS+TR
on a generic micronutrient level are presented below. The
predictor (micronutrient) is assumed standardised to have a
standard deviation of 1. The slope therefore reflects
the detectable difference in SS+TR, for a 1 SD differ-
ence in the predictor, at a power of 80 % with a type
I error rate of 0.05:
From Donahue et al., the observed effect of a 1 SD
difference in each predictor on SS+TR reached as high
as 0.64 (Total n-6 fatty acids), 0.81 (n-6:n-3 ratio), and
0.61 (LA:ALA ratio) all of which should be detectable in
a sample of at least 387 subjects.
Results
Demographics
Maternal characteristics are displayed in Table 1 with a
comparison of participants and those lost to follow-up.
91.4 % of the 542 women were of “white Irish”, 6.7 % of
“white other”, 0.3 % of “African”, 0.5 % of “Chinese”,
0.1 % of “Indian” and 1.0 % of “Filipino/South East
Asian” ethnicity. 78.1 % of the women had achieved 3rd
level education while 21.9 % had not. 4.0 % of women
reported smoking in early pregnancy while 96.0 % re-
ported being non-smokers. Participants were signifi-
cantly older and had a lower early pregnancy weight and
BMI than those lost to follow up but there was no differ-
ence in gestational weight gain or neonatal anthropom-
etry between the groups. A comparison of maternal and
infant characteristics of infants with and without cir-
cumference and skinfold measurements was also made
(Table 2). No difference in maternal characteristics or
neonatal weight or length was observed between those
with and without these measurements.
Maternal dietary intake and underreporting
Adequacy of dietary maternal micronutrient intake in each
trimester when compared to Irish RDA’s for pregnancy
[28] is displayed in Table 3 The percentage of participants
who met the RDA’s for pregnancy was particularly low for
folate, vitamin C and vitamin D (9.8 % in trimester 1,
21.3 % in trimester 2 and 7.2 % in trimester 3 respectively).
Maternal dietary intakes and a comparison of study
groups is displayed in Additional file 1: Table S1. Underre-
porting was found to affect the associations observed in
the final multiple linear regression models. Therefore
underreporters were removed from this analysis (Table 4).
Associations between maternal micronutrient intake and
neonatal anthropometry
Statistically significant multiple linear regression models
for the association between maternal micronutrient in-
takes and neonatal anthropometry are displayed in
Table 4 and were as follows: birthweight was negatively
associated with maternal trimester 3 vitamin D intake
and positively associated with trimester 3 vitamin B12
intake R2adj 19.8 % (F = 13.19, p <0.001), birth length
was positively associated with trimester 3 magnesium
intake R2adj 12.9 % (F = 8.06, p <0.001), neonatal ab-
dominal circumference was positively associated with
maternal trimester 3 retinol intake and negatively associ-
ated with trimester 3 vitamin E and selenium intake
R2adj 11.9 % (F = 2.93, p = 0.002), neonatal waist:length
ratio was negatively associated with trimester 3 magne-
sium intake R2adj 20.1 % (F = 3.92, p <0.001), SSF:TSF
ratio was negatively associated with trimester 1 selenium
intake R2adj7.2 % (F = 2.00, p = 0.047). There was no as-
sociation between reported maternal vitamin or mineral
supplement use during pregnancy and any of the neo-
natal anthropometric measurements, ratios or sums of
skinfold thicknesses and therefore all micronutrient as-
sociations described are from dietary intake alone.
Discussion
The main findings of this analysis which examined
the associations between neonatal anthropometry and
micronutrient intakes were that birthweight was nega-
tively associated with trimester 3 vitamin D intake
and positively associated with trimester 3 vitamin B12
intake while birth length was positively associated
with trimester 3 vitamin B12 intake. Abdominal cir-
cumference was positively associated with maternal
trimester 3 retinol intake and negatively associated
with trimester 3 vitamin E and selenium intake.
When ratios for estimation of neonatal adiposity were
calculated, it was found that the subscapular:triceps
skinfold thickness ratio, a measure of central adiposity,
was negatively associated with trimester 1 selenium intake
while the waist circumference:length ratio, another meas-
ure of central adiposity, was negatively associated with tri-
mester 3 magnesium intake. Our finding that birthweight
was negatively associated with trimester 3 vitamin D in-
take is contrary to to the findings other studies [31, 32].
This may be due, in part, to the nature of our cohort, in
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which there was a high prevalence of macrosomia as a US
randomised control trial of vitamin D supplementation in
pregnancy by Wagner et al. [33] found that, when macro-
somia was examined, the group supplemented with the
highest doses of vitamin D gave birth to significantly more
infants of normal birthweight than those supplemented
with lower doses.
Maternal trimester 3 vitamin B12 intake was positively
associated with birthweight. This effect on fetal growth
is thought to be due to the activity of vitamin B12 as a
Table 1 General maternal background characteristics during pregnancy and neonatal anthropometry with comparison of
participants and those that were lost to follow-up
Lost to follow-up Participated
N Mean SD n Mean SD p
Mother age (yrs) 222 32.17 4.75 483 32.87 3.93 0.041
Mother height (cm) 240 165.10 16.58 542 165.27 11.86 0.868
Mother weight (kg) 238 76.48 16.52 541 72.38 12.94 <0.001
Mother BMIa (kg/m2) 237 27.61 6.01 540 26.30 4.38 0.001
Gestational Weight Gain (kg) 93 12.87 5.07 273 13.39 4.55 0.359
Days per week walking ≥30 minb 94 3.43 1.81 427 3.48 1.79 0.772
Moderate activity (min per week) 57 59.65 43.01 309 66.15 43.45 0.299
Neonatal weight (kg) 207 4.01 604.18 542 4.02 4.58 0.633
Neonatal length (cm) 184 52.74 2.56 454 52.75 2.33 0.964
Neonatal MUACc (cm) 43 12.57 1.23 223 12.39 1.51 0.475
Neonatal abdominal circd (cm) 43 33.47 2.26 222 33.40 2.11 0.844
Neonatal waist circd:hip ratio 42 33.43 2.27 221 33.63 2.32 0.606
Neonatal thigh circd (cm) 43 16.23 1.44 222 16.16 1.67 0.801
Neonatal biceps skinfold (mm) 33 6.85 1.72 186 6.78 1.46 0.806
Neonatal triceps skinfold (mm) 33 6.94 1.50 186 7.00 1.52 0.822
Neonatal subscapular skinfold (mm) 33 7.14 2.07 186 6.90 1.49 0.423
Neonatal thigh skinfold (mm) 33 8.08 2.20 186 7.90 1.76 0.605
Neonatal waist:length circd ratio 37 0.63 0.04 182 0.64 0.05 0.775
Neonatal SOSFe (mm) 33 29.00 6.45 186 28.58 5.18 0.677
Neonatal sum TSFf and SSFg (mm) 33 14.08 3.19 186 13.90 2.69 0.736
Neonatal SSFg:TSFf ratio 33 1.04 0.23 186 1.00 0.19 0.332
Neonatal waist:hip circd ratio 42 1.00 0.05 221 1.00 0.06 0.312
“n” denotes number, p <0.05 was considered statistically significant (2-tailed significance generated from independent sample t-tests)
Abbreviations: aBMI body mass index, bmin minutes, cMUAC mid-upper arm circumference, dcirc circumference, eSOSF sum of skinfolds, fTSF triceps skinfold, gSSF
subscapular skinfold
Table 2 Comparison of maternal and offspring characteristics between participants with and without skinfold measurements
No skinfolds Skinfolds
n Mean SD n Mean SD P
Mother age (yrs) 309 32.89 3.82 176 32.85 4.11 0.905
Mother height (cm) 321 165.71 11.32 227 164.66 12.45 0.304
Mother weight (kg) 322 72.21 13.05 226 72.81 12.86 0.591
Mother BMI1 (kg/m2) 320 26.12 4.39 226 26.61 4.40 0.200
Gestational weight gain (kg) 152 13.18 4.37 121 13.65 4.78 0.399
Days per week walking ≥30 min2 255 3.51 1.85 178 3.43 1.71 0.637
Moderate activity (min per week) 191 65.97 44.67 122 65.74 41.50 0.963
Birth_weight (kg) 319 4.00 4.55 223 4.06 459.42 0.127
BirthLength (cm) 282 52.66 2.44 176 52.89 2.18 0.316
Abbreviations: 1Body Mass Index, 2Minutes
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Table 3 Micronutrient RDAs for pregnancy and proportion of women meeting these RDAs with comparison of frequency of
meeting RDAs between the control and intervention groups
RDA n meeting RDA % meeting RDA p-value
Trimester 1 Riboflavin 1.3 mg/d 460 100 1.0
Trimester 2 Riboflavin 1.6 mg/d 466 100 1.0
Trimester 3 Riboflavin 1.6 mg/d 461 100 1.0
Trimester 1 Thiamine 100ug/MJ 460 100 1.0
Trimester 2 Thiamine 100ug/MJ 466 100 1.0
Trimester 3 Thiamine 100ug/MJ 461 100 1.0
Trimester 1 Niacin 1.6 mg/MJ 460 100 1.0
Trimester 2 Niacin 1.6 mg/MJ 466 100 1.0
Trimester 3 Niacin 1.6 mg/MJ 461 100 1.0
Trimester 1 Vitamin C 60 mg/d 238 51.7 0.008
Trimester 2 Vitamin C 80 mg/d 121 26.0 0.026
Trimester 3 Vitamin C 80 mg/d 98 21.3 0.189
Trimester 1 Vitamin B6 15ug/g protein 460 100 1.0
Trimester 2 Vitamin B6 15ug/g protein 466 100 1.0
Trimester 3 Vitamin B6 15ug/g protein 461 100 1.0
Trimester 1 Folate 500ug/d 45 9.8 0.077
Trimester 2 Folate 500 ug/d 37 7.9 0.594
Trimester 3 Folate 500 ug/d 54 11.7 0.145
Trimester 1 Vitamin B12 1.4 ug/d 460 100 1.0
Trimester 2 Vitamin B12 1.6 ug/d 466 100 1.0
Trimester 3 Vitamin B12 1.6 ug/d 461 100 1.0
Trimester 1 Vitamin D 10 ug/d 8 1.7 N/A*
Trimester 2 Vitamin D 10 ug/d 12 2.6 N/A*
Trimester 3 Vitamin D 10 ug/d 33 7.2 0.965
Trimester 1 Calcium 800 mg/d 460 100 1.0
Trimester 2 Calcium 1200 mg/d 228 48.9 0.809
Trimester 3 Calcium 1200 mg/d 264 57.3 0.482
Trimester 1 Potassium 3100 mg/d 335 72.8 0.449
Trimester 2 Potassium 3100 mg/d 368 80.0 0.010
Trimester 3 Potassium 3100 mg/d 373 80.9 0.004
Trimester 1 Iron 14 mg/d 247 53.7 0.003
Trimester 2 Iron 15 mg/d 178 38.2 0.028
Trimester 3 Iron 15 mg/d 190 41.2 0.021
Trimester 1 Zinc 7 mg/d 460 100 1.0
Trimester 2 Zinc 7 mg/d 466 100 1.0
Trimester 3 Zinc 7 mg/d 461 100 1.0
Trimester 1 Selenium 55 ug/d 299 65.0 0.005
Trimester 2 Selenium 55 ug/d 297 63.7 0.005
Trimester 3 Selenium 55 ug/d 274 59.4 0.036
Trimester 1 Iodine 130 ug/d 460 100 1.0
Trimester 2 Iodine 130 ug/d 466 100 1.0
Trimester 3 Iodine 130 ug/d 461 100 1.0
Trimester 1 Sodium 2400 mg/d 353 76.7 0.131
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coenzyme in the conversion of homocysteine to methio-
nine which is in turn converted to S-adenosylmethionine.
In vitamin B12 deficiency, this reaction is reduced result-
ing in increased levels of homocysteine which alters the
placental vascular endothelium leading to fetal growth
restriction [34, 35]. Levels of S-adenosylmethionine are
also concomitantly reduced, decreasing the level of DNA
methylation and are thereby thought to epigenetically re-
duce fetal growth [36, 37]. Study results been conflicting
regarding the association of vitamin B12 and birthweight
Table 3 Micronutrient RDAs for pregnancy and proportion of women meeting these RDAs with comparison of frequency of
meeting RDAs between the control and intervention groups (Continued)
Trimester 2 Sodium 2400 mg/d 364 78.1 0.365
Trimester 3 Sodium 2400 mg/d 335 72.7 0.003
Trimester 1 Vitamin A 600 ug/d 119 25.9 <0.001
Trimester 2 Vitamin A 700 ug/d 48 10.3 0.881
Trimester 3 Vitamin A 700 ug/d 119 25.8 <0.001
Based on Irish RDAs [28]. Insufficient data to provide recommendations for: ß Carotene and other carotenoids Pantothenic acid, Vitamin K, Magnesium,
Molybdenum, Manganese, Biotin, Fluoride, Chloride, Chromium and Vitamin E. Definite underreporters excluded (Goldberg Ratio ≤0.9). The population compliance
method was used to determine frequency of compliance with RDAs [35]. Chi-squared tests used to compare frequency of compliance with RDAs between the
control and intervention groups. *N/A as zero women in the intervention group met the RDA for vitamin D in trimesters 1 or 2
Table 4 Maternal micronutrient intakes associated with neonatal anthropometry- final models
B SEB p R2adj f p
Birthweight
Trimester 2 vitamin D/10 MJ −19.62 6.558 0.003 0.198 13.19 <0.001
Trimester 3 vitamin B12/10 MJ 104.73 33.349 0.002
Birth length
Trimester 3 magnesium/10 MJ 0.01 0.002 0.010 0.129 8.06 <0.001
Abdominal circumference
Trimester 3 selenium/10 MJ −0.02 0.008 0.028
Trimester 3 retinol/10 MJ 0.001 0.001 0.020 0.119 2.93 0.002
Trimester 3 vitamin E/10 MJ −0.11 0.053 0.039
Thigh circumference
Trimester 3 magnesium/10 MJ −0.01 0.002 0.018 0.052 2.16 0.042
Hip circumference
Trimester 3 vitamin B6/10 MJ 1.05 0.329 0.002 0.100 3.31 0.003
Mid-upper arm circumference
Trimester 2 sodium/10 MJ −0.0002 0.0001 0.081
Trimester 2 vitamin B6/10 MJ −0.23 0.052 <0.001 0.260 6.58
Trimester 3 selenium/10 MJ −0.01 0.005 0.002 <0.001
Subscapular skinfold thickness
Trimester 1 vitamin C/10 MJ 0.004 0.002 0.024 0.088 2.39 0.021
Trimester 1 vitamin B12/10 MJ 0.50 0.246 0.045
Subscapular:triceps skinfold ratio
Trimester 1 selenium/10 MJ −0.002 0.001 0.026
Trimester 2 iodine/10 MJ 0.0003 0.0002 0.092 0.072 2.00 0.047
Trimester 2 retinol/10 MJ 9.632E-05 0.00005 0.050
Waist circumference:length ratio
Trimester 2 magnesium/10 MJ −0.0003 0.0001 0.001 0.201 3.92 <0.001
Multiple linear regression analysis controlling for maternal education, pre-pregnancy BMI, length of gestation (d), neonate gender, study group (intervention/control),
supplement use (yes/no) and significantly associated macronutrient intake (%TE). Definite underreporters (Goldberg ratio ≤0.9) removed. p <0.05
considered statistically significant
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with some reporting a positive association [38–41] and
others observing no such association [42–46]. A recent
study which did not observe an association between birth
weight or length and maternal vitamin B12 levels found
that when the ratio of maternal plasma folate to vitamin
B12 was examined there was an inverse association with
neonatal weight, length, head circumference and chest cir-
cumference but no association was observed with neo-
natal triceps or subscapular skinfold thickness [43]. No
such inverse association was observed in our analysis,
however. Another study reported a positive association
between birthweight and absolute vitamin B12 and also
observed a further adverse effect on birthweight of folate
supplementation in women with poor vitamin B12 status
[38]. Therefore, increased folate levels resulting in
increased homocysteine levels when vitamin B12 is rate-
limiting may negatively affect birthweight.
The positive association of maternal trimester 3 mag-
nesium intake with birth length may be due to the role
of magnesium in skeletal growth with the greatest rate
of mineral accretion occurring in the 3rd trimester [47].
A study by Doyle et al. [48] found that magnesium intake
of 513 women in trimester 1 was similarly associated with
birth length but that magnesium supplementation in later
trimesters did not affect infant size. Similarly, the ALSPAC
study found that bone mineral density and height of 9 year
old children was associated with maternal magnesium in-
take during late pregnancy [49] and another Tasmanian
study found the bone mass of 8 year old children was
positively associated with maternal magnesium intake in
trimester 3 [50]. This was hypothesised however to be me-
diated by fetal programming of growth by maternal diet
during pregnancy rather than by fetal bone mineralisation
[49, 50]. The finding that trimester 2 magnesium intake
was negatively associated with neonatal waist:length cir-
cumference, a marker of central adiposity [20], may also
due to an association with increased neonatal length. A
further possible explanation for this association may be
that is a maker of overall healthy diet [51] although mater-
nal BMI and macronutrient intake was controlled for in
all of our final models. In addition, there is also evidence
that low blood magnesium levels and magnesium defi-
ciency are associated with inflammation in adults and chil-
dren [52–54], and with insulin insensitivity and metabolic
syndrome and consequently central adiposity [52, 55].
Selenium was negatively associated with two measures
of central adiposity, trimester 3 selenium with the ab-
dominal circumference and trimester 1 selenium with
the subscapular:triceps skinfold ratio. The main function
of selenium is as an antioxidant due to its incorporation
into selenoproteins which have are involved in glutathione
peroxidase production and many other anti-inflammatory
mechanisms, not all of which are yet understood [56]. In-
creased selenium levels may modulate selenoprotein gene
expression and selenium supplementation has been found
to be associated with reduced TNF-α levels in vitro and in
vivo [57, 58]. However, selenium can also act through
modulating the effect of TNF-α via TNF-α receptors [59]
and can up-regulate production of TNF-α in individuals
in whom it is under-produced for example individuals at
risk of carcinoma [60]. It therefore acts as an anti-
proliferative agent and is also a component of many en-
zymes in the body. Low selenium status in pregnancy has
been linked with reduced birthweight [61–63] and with
gestational diabetes and maternal glucose intolerance
[64–66]. Although we found that dietary selenium was
negatively associated with central adiposity in this cohort,
we did not observe an association with birthweight.
Studies exploring the relationship between selenium
and birthweight, unlike this study, have examined
serum rather than dietary selenium levels and have
proposed that oxidative stress in these pregnancies
may have resulted in selenium depletion.
Finally, maternal trimester 2 and 3 retinol intakes were
positively associated with central adiposity. Low mater-
nal retinol status has been found to be associated with
reduced offspring birthweight by several studies [67–70]
although other studies have reported opposing results
[71–74]. However, as with all micronutrients associated
with neonate adiposity in this cohort, the association
with neonatal adiposity specifically, rather than just
birthweight, has not been reported in the literature to
the best of the authors’ knowledge.
Limitations of this study were that blood micronu-
trient levels were not measured although extensive diet-
ary records were obtained from 3-day food diaries at
each trimester of pregnancy. Detailed information on
micronutrient supplementation in pregnancy was not
available as this was a secondary analysis. A further limi-
tation was that we were unable to rule out the possibility
of micronutrients synergistic activity as mentioned above.
Equally, it is possible that micronutrients may have been
acting as markers of improved maternal health behaviours
[10] although we attempted to reduce the likelihood of
this by controlling for BMI and controlling for any macro-
nutrients associated with neonatal anthropometry in all
final models. Finally, an additional limitation was that cir-
cumference and skinfold thickness measurements were
not available for the full cohort resulting in reduced statis-
tical power of the analysis. No significant difference in ma-
ternal or offspring characteristics was observed when
infants with and without circumference and skinfold mea-
surements were compared, however. There has been little
research into intakes of micronutrients in overweight and
obese pregnant women with no studies specifically explor-
ing the association with offspring adiposity and the ROLO
study was appropriate for exploration of these associations
as there was a high level of overweight (mean BMI in early
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pregnancy 26.3 kg/m2) and macrosomia (mean birth-
weight of 4.02 kg) in this cohort. Further research is ne-
cessary to define such relationships and determine
optimum maternal micronutrient intakes for overweight
or obese pregnancies.
Conclusions
Dietary intakes of several micronutrients were poor
during pregnancy in women from a developed country.
Maternal dietary micronutrient intake is associated with
neonatal anthropometry even in women not at risk of
malnutrition and further research is necessary to deter-
mine optimal micronutrient intake in overweight and
obese women.
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